Publications

Journal Article
Review Research Support, Non-U.S. Gov't
Ppublish 2 citations
Electronic publication date
September 25, 2024

View on Pubmed.gov 39114917 | View on doi.org 10.1161/ATVBAHA...

Role of Antibodies and Their Specificities in Atherosclerotic Cardiovascular Disease.

Search for publications in this journal Arterioscler Thromb Vasc Biol - 44(10):2154-2168

Abstract

Atherosclerosis is a lipid-driven chronic inflammatory disease that is modulated by innate and adaptive immunity including humoral immunity. Importantly, antibody alterations achieved by genetic means or active and passive immunization strategies in preclinical studies can improve or aggravate atherosclerosis. Additionally, a wide range of epidemiological data demonstrate not only an association between the total levels of different antibody isotypes but also levels of antibodies targeting specific antigens with atherosclerotic cardiovascular disease. Here, we discuss the potential role of atherogenic dyslipidemia on the antibody repertoire and review potential antibody-mediated effector mechanisms involved in atherosclerosis development highlighting the major atherosclerosis-associated antigens that trigger antibody responses.

References

No references provided.

Cited by 2 citations (total)

Journal Article Review

Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular disease.

Electronic publication date April 28, 2025

Search for publications in this journal NPJ Metab Health Dis

Patrick H Andrews [...] Coleen A McNamara et al.

Glucose 6-phosphate dehydrogenase deficiency (G6PD-d) is the most common enzymopathy in the world, occurring in 5-8% of the global population...

Journal Article Review

Orticumab: the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy.

Electronic publication date July 3, 2025

Search for publications in this journal Curr Opin Lipidol

Christopher J Farina [...] Jan Nilsson et al.

PURPOSE OF REVIEW

Myocardial infarction survivors are at a high risk of a recurrent event despite receiving guideline preventive therapy. There...

Conflict of interest statement

None.

MeSH

Specialties

Substances